2 |
Smith EMD, Aggarwal A, Ainsworth J, Al-Abadi E, Avcin T, Bortey L, Burnham J, Ciurtin C, Hedrich CM, Kamphuis S, Levy DM, Lewandowski LB, Maxwell N, Morand EF, Ozen S, Pain CE, Ravelli A, Saad Magalhaes C, Pilkington CA, Schonenberg-Meinema D, Scott C, Tullus K, Beresford MW; cSLE T2T International Task Force. Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. Ann Rheum Dis 2023:ard-2022-223328. [PMID: 36627168 DOI: 10.1136/ard-2022-223328] [Reference Citation Analysis]
|
3 |
Lai C, Sun Y, Chen W, Liao H, Chen M, Tsai C, Huang D, Chou C, Chang D. Risk factors for mortality in systemic lupus erythematosus patients: Analysis of adult and pediatric cohorts in Taiwan. Journal of the Chinese Medical Association 2022;85:1044-1050. [DOI: 10.1097/jcma.0000000000000783] [Reference Citation Analysis]
|